
Chinese drug discovery services company established on 19 November 2010 as the majority owned subsidiary through which Sundia MediTech entered the Shijiazhuang National High-tech Industrial Development Zone in Hebei, forming a northern research base to complement the group's Shanghai operations. The parent Sundia MediTech (Shanghai) was founded in 2004 by senior scientists and managers from the global pharmaceutical industry and is one of China's leading drug research service companies, offering comprehensive and cost effective services covering innovative chemical drug research, generic chemical drug development and biologic drug screening, evaluation and testing; it now operates as part of the BioDuro-Sundia platform.
Deja tu valoración